China Spinal Fusion Market Size- By Device Type- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

Introduction and Overview

Spinal fusion, also known as spondylosyndesis or spondylodesis, is the procedure of repairing anomalies or problems with the tiny spine bones, or verterbrae. It is the joining of two spines so that they can harden into one bone. The primary goals of spinal fusion are to restore spine stability and reduce discomfort during movement in disorders such as tumors, scoliosis, broken vertebrae, spinal stenosis, and herniated disks, among others.

The COVID-19 pandemic outbreak has sparked a race to develop therapeutic and preventive technologies, with China leading the way. Multiple clinical trials are presently ongoing as a result of China's coronavirus cases, which are spreading at an alarming rate. The medical device industry's intense focus on creating medications and vaccines that can also be used to detect and treat COVID-19 has resulted in an increase in clinical trial rates.

Scope of the Report

Report Metric Details:

Market size available for years: 2019-2033

Base year considered: 2022

Forecast period: 2023-2033

Segments covered: By Device Type

Regions covered: Beijing, Changsha, Hangzhou, Shenzhen, Wuhan, Others

Companies Covered: B. Braun Aesculap and Weigao, International N.V, Orthofix, Orthopaedic Device Co, Ltd., Stryker Corporation, Zimmer Holding Inc, Others.

Market Segmentation:

By Device Type: Based on the Device Type, China Spinal Fusion Market is segmented as; Spinal Decompression, Spinal Fusion, Fracture Repair Devices, Arthroplasty Devices, Non-Fusion Devices.

By Region: This research also includes data for North America, Latin America, Asia Pacific, Europe, MEA.

Product Code: HLCA2373

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the China Spinal Fusion Market

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. China Spinal Fusion Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in China Spinal Fusion Market

7. China Spinal Fusion Market, By Device Type (USD Million)

7.1. China Spinal Fusion Market Value Share and Forecast, By Device Type, 2023-2033
7.2. Spinal Decompression
7.3. Spinal Fusion
7.4. Fracture Repair Devices
7.5. Arthroplasty Devices
7.6. Non-Fusion Devices

8. China Spinal Fusion Market Forecast, 2019-2033 (USD Million)

8.1. China Spinal Fusion Market Size and Market Share

9. China Spinal Fusion Market, By Device Type, 2019-2033 (USD Million)

9.1. China Spinal Fusion Market Size and Market Share By Device Type (2019-2026)
9.2. China Spinal Fusion Market Size and Market Share By Device Type (2027-2033)

10. China Spinal Fusion Market, By Region, 2019-2033 (USD Million)

10.1. China Spinal Fusion Market Size and Market Share By Region (2019-2026)
10.2. China Spinal Fusion Market Size and Market Share By Region (2027-2033)
10.3. Beijing
10.4. Changsha
10.5. Hangzhou
10.6. Shenzhen
10.7. Wuhan
10.8. Others

11. Company Profile

11.1. B. Braun Aesculap and Weigao
- 11.1.1. Company details
- 11.1.2. Financial outlook
- 11.1.3. Product summary
- 11.1.4. Recent developments
11.2. International N.V
- 11.2.1. Company details
- 11.2.2. Financial outlook
- 11.2.3. Product summary
- 11.2.4. Recent developments
11.3. Orthofix
- 11.3.1. Company details
- 11.3.2. Financial outlook
- 11.3.3. Product summary
- 11.3.4. Recent developments
11.4. Orthopaedic Device Co, Ltd.
- 11.4.1. Company details
- 11.4.2. Financial outlook
- 11.4.3. Product summary
- 11.4.4. Recent developments
11.5. Stryker Corporation
- 11.5.1. Company details
- 11.5.2. Financial outlook
- 11.5.3. Product summary
- 11.5.4. Recent developments
11.6. Zimmer Holding Inc
- 11.6.1. Company details
- 11.6.2. Financial outlook
- 11.6.3. Product summary
- 11.6.4. Recent developments
11.7. Others